News

Connect with Berkshire Biomedical Leadership Before Campaign Ends

Connect with Berkshire Biomedical Leadership Before Campaign Ends

Engage with Berkshire Biomedical Before Campaign Concludes

As the equity crowdfunding campaign on StartEngine approaches its conclusion, Berkshire Biomedical will host its final live webinar. This event is scheduled for Thursday, and it serves as a unique opportunity for current and potential supporters to interact directly with the company's leadership and ask questions before the campaign concludes.

Key Details of the Upcoming Webinar

The forthcoming session will feature John Timberlake, President and CEO of Berkshire Biomedical, alongside Tom King, Senior Advisor to the Company. During this discussion, they will delve into the applications of COPA™ (Computerized Oral Prescription Administration), the proprietary drug delivery platform that is currently in development. Initially focused on Medication for Opioid Use Disorder (MOUD), COPA’s design is set to encompass various therapeutic areas where accuracy, safety, and adherence play essential roles.

Exploring Coping Mechanisms and Broader Applications

The topics during the webinar will highlight COPA’s potential relevance in treating chronic pain, ADHD, epilepsy, Alzheimer's disease, and preferences in post-surgical recovery. This is also an opportunity for clinical research organizations and pharmaceutical partners to understand how COPA can support their initiatives.

Live Q&A Session

Attendees will have the chance to ask questions during this live session. It's important to note that this will be the company's last webinar before closing its offering on StartEngine, making it a critical chance for engagement.

About Berkshire Biomedical Corporation

Berkshire Biomedical Corporation is a privately held medical device company dedicated to pioneering biometric technologies integrated with compliant cloud-based systems. Their objective is to ensure precise and accurate personalized medication delivery exclusively to the Authenticated Intended User (AIU).

The centerpiece of their innovation is the Computerized Oral Prescription Administration System (COPA). This handheld, automated device is designed to dispense both controlled and non-controlled liquid oral medications to AIUs, confirmed through dual biometric verification, including fingerprint and dentition recognition.

Future Directions for COPA

Once regulatory approval is achieved, Berkshire Biomedical intends to explore COPA's deployment for delivering oral liquid methadone as part of opioid use disorder treatment. There’s also potential to apply COPA for delivering other controlled medications for pain management, meeting the needs of patients who would benefit from its advanced features.

The development of COPA was bolstered by a $2.0 million Fast-Track Small Business Innovation Research grant from the National Institute of Drug Abuse at the National Institutes of Health, illustrating the commitment to research and innovation.

Looking ahead, the company aims to expand the application of COPA to a wider range of therapeutic drugs and clinical scenarios, alongside collaborations with organizations that emphasize data analytics to enhance patient outcomes and minimize risks.

It’s essential to note that while the COPA System is currently under development, it has not yet been reviewed by the U.S. Food and Drug Administration and is unavailable for commercial sale.

Frequently Asked Questions

What is the purpose of the final webinar hosted by Berkshire Biomedical?

The final webinar aims to provide an opportunity for supporters to engage with the company's leadership and learn more about their drug delivery technology, COPA.

Who are the speakers at the webinar?

The webinar will feature John Timberlake, the President and CEO, and Tom King, who is a Senior Advisor to the Company.

What topics will be covered during the webinar?

Topics include the broader applications of COPA and its potential relevance in various therapeutic areas including chronic pain and Alzheimer's disease.

How can I participate in the live Q&A session?

Participants can ask questions live during the webinar, making it an interactive opportunity for engagement.

Is COPA currently available for commercial sale?

No, the COPA System is still under development and has not been reviewed or approved for sale by regulatory bodies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Dr. Obeng Joins WellcomeMD with Special Offer for Patients

Updated Category News Views 47

New Beginnings in Concierge Medicine In late October, WellcomeMD opened its doors to Dr. Paa-Kofi Obeng—an arrival greeted with considerable anticipation in Richmond's medical scene. This isn't just any run-of-the-mill staff addition; Dr. Obeng brings with him over a decade of experience from places like the Veterans Administration Medical Center. He's armed with a...

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 56

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
Halfday Iced Tea Shakes Up U.S. Retail Scene

Updated Category News Views 142

Halfday's Meteoric Rise in the U.S. Market Sometimes, you pick up a can of iced tea, and it just changes the game. That’s exactly what Halfday is doing, stepping on the accelerator and leaving traditional iced tea brands in the dust. With their latest announcement, they've snagged the title of the fastest-growing modern tea brand in U.S. multi-outlet retail. It's the...

Continue Reading
Webull Faces FINRA Fine and Legal Battle Ahead

Updated Category News Views 187

Webull's Compliance Headache Webull’s been knocked around again. This time, the Financial Industry Regulatory Authority (FINRA) slapped it with a hefty $4.2 million fine. Talk about a hit to the wallet! It all boils down to them failing to roll out some basic anti-money laundering (AML) and other crucial compliance programs. This is no small oversight, and it's got...

Continue Reading
Clinch Scores Big with Two Prestigious Industry Honors

Updated Category News Views 101

Clinch's Dual Triumph in Advertising Innovation No one throws a ticker symbol over their cereal for recognizing brilliance, but when an outfit like Clinch gets double applause at the big dance, even we old-timers have to tip our hats. On November 16, 2026, the advertising world saw some fireworks. Clinch took home not one but two hefty awards—the kind that say you've...

Continue Reading
FDA Changes Shake Up Medtech Inspections Landscape

Updated Category News Views 124

Inspecting the Changing FDA Landscape If you’ve been treating FDA inspections like a ride down memory lane, it's time for a wake-up call. What F. David Rothkopf plans to tell the medical device teams at the MEDevice Silicon Valley event is simple: the game has changed. The FDA’s Quality Management System Regulation (QMSR) that kicked in on February 2, 2026, isn’t...

Continue Reading
Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 93

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Luxury Villa Cashback Offers Entice Travelers in November

Updated Category News Views 134

A November Bonanza for Villa Bookings Who doesn't love having a few extra bucks in their pocket, especially when they come with the allure of luxury travel? Villas of Distinction is rolling out what they call a 'November Cashback Offer,' and for those with the wallet—and wanderlust—to match, it could be a tempting proposition. Hanging the bait of up to $2,000 cashback...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 150

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 92

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading

Top 5 Most Recently Viewed Articles

Macquarie's Optimistic Outlook for Chinese Internet Stocks

Updated Category News Views 155

Macquarie's Recent Upgrades in the Chinese Internet Sector Macquarie has taken a positive stance on various Chinese internet stocks, highlighting the stronger fundamentals and increased earnings visibility that have emerged in the sector. Analysts believe that ongoing support from the government will further bolster these companies, leading to enhanced growth...

Continue Reading
Highmark Health's Impressive Financial Growth and Future Outlook

Updated Category News Views 238

Highmark Health Reports Impressive Financial Results In a remarkable update, Highmark Health shared its consolidated financial outcomes for the first half of 2025, revealing a revenue of $16.5 billion, alongside a net income of $329 million. This performance is indicative of the organization's robust positioning within the healthcare sector, despite facing ongoing...

Continue Reading
Roblon Reports Steady Q1 Performance Amid Market Challenges

Updated Category News Views 136

Roblon A/S Delivers Steady Financial Results in Q1 2024/25 Roblon’s revenue and earnings for the first quarter of 2024/25 meet expectations The Board of Directors at Roblon A/S has reviewed and approved the interim report reflecting the company’s performance over the initial three months of the financial year 2024/25. This period showcased resilient revenue figures,...

Continue Reading
Weis Markets Achieves Notable Growth in Third Quarter 2025

Updated Category News Views 188

Weis Markets Shows Strong Third Quarter Performance Weis Markets, Inc. (NYSE: WMK) has reported impressive financial results for its third quarter. The company saw an increase of 2.5% in comparable store sales excluding fuel, showcasing its resilience in a fluctuating economic landscape. Overview of Third Quarter Results In the 13-week period ending September 27, 2025,...

Continue Reading
Innovative Renal Care Faces Investigation Over Major Data Breach

Updated Category News Views 156

Innovative Renal Care Under Investigation for Data Breach In recent developments, Innovative Renal Care has come under scrutiny due to a significant data breach that has alarmed both the company and its patients. The investigation, spearheaded by Federman & Sherwood, seeks to uncover the full extent of the incident and understand its implications. Details of the Data...

Continue Reading